Fidelity Investments’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
HCL
JT
PM
GI
Fidelity Investments's ATEX Position: Q2 2026 in Review
Fidelity Investments increased its Anterix (ATEX) stake by 174% in Q2 2026, buying an estimated $13.8M and bringing the position to 370,400 shares worth $38.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1632.
Fidelity Investments first reported a position in ATEX in Q1 2021 and has held it in 22 quarters since. 172 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.
- Fidelity Investments held 370,400 shares of Anterix worth $38.1M as of Q2 2026.
- Fidelity Investments bought 235,105 Anterix shares in Q2 2026, an estimated $13.8M.
- Anterix made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #1632 holding.
- Fidelity Investments first reported a position in Anterix in Q1 2021 and has held it in 22 quarters since.
- 172 funds tracked by Wall St. Rank held Anterix as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.